Team Gleason & Synchron Renew Partnership to Expand BCI Access to the ALS Community 

Team Gleason and Synchron are proud to announce the renewal and expansion of our partnership, which started in 2022. United by a shared mission, we remain committed to improving the quality of life for individuals living with ALS through meaningful collaboration, community engagement, and transformative innovation. 

Synchron is developing a brain-computer interface* (BCI) designed to enable people with motor impairment to control digital devices by translating thought into action. The system is implanted through a minimally invasive procedure (not open-brain surgery) and is being evaluated for its impact on independence, autonomy, and privacy.

As research continues, both organizations remain committed to ensuring the ALS community plays a central role in shaping the future of this technology—through insights, feedback, and direct participation.

Get Involved. Stay Informed. Shape the Future.
Join the Synchron BCI Community—a growing network of pALS, cALS, caregivers, and clinicians collaborating to influence the next generation of assistive technology. As a member, you will:

• Learn more about emerging BCI research.
• Have opportunities to participate in paid surveys and product feedback sessions.
• Gain early access to educational content.
• Help ensure new tools are built with and for the ALS community.  

Join the Synchron BCI Community at Synchronbci.com. 

*Note: The Synchron BCI system is an investigational device and is not approved for commercial use. Participation in the community does not imply eligibility for trials or guarantee future access to the technology. All research is conducted under appropriate regulatory oversight.

About Team Gleason

Team Gleason Foundation was founded by former New Orleans Saints player, Steve Gleason, after his diagnosis with Amyotrophic Lateral Sclerosis (ALS) in 2011. Team Gleason’s mission is to improve life for people living with ALS by delivering innovative technology and equipment, as well as providing and empowering an improved life experience. For more information on how to help people living with ALS have the resources and the opportunities to not only continue living, but continue living productive, purposeful, and meaningful lives, please visit www.TeamGleason.org.

About Synchron

Synchron is a neurotechnology company developing an endovascular brain-computer interface (BCI) designed to restore functionality in people with severe paralysis. The clinical-stage company is developing a neuroprosthesis to restore motor signaling to control digital devices and autonomy for individuals with motor impairment. Synchron is headquartered in New York City. For more information, visit www.synchron.com. Follow us @synchroninc.

Media
Kimberly Ha
Synchron
[email protected]